Cytoplasmic Dynein 1 Intermediate Chain 1 (Dync1I1) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
DYNC1I1 (Cytoplasmic Dynein 1 Intermediate Chain 1) is a core component of the cytoplasmic dynein-1 motor complex, a minus-end-directed microtubule motor that mediates retrograde axonal transport in neurons. DYNC1I1 serves as a critical link between the dynein heavy chain motor and cargo adaptor proteins, enabling the transport of diverse cargoes from distal neuronal processes back to cell bodies. Dysfunction of DYNC1I1 and axonal transport impairment is increasingly recognized as an early and pivotal event in the pathogenesis of Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD) Kaur et al., 2022.
DYNC1I1 is a ~71.5 kDa protein encoded by the DYNC1I1 gene located on chromosome 7q32. The protein contains several functionally distinct domains:
| Domain | Amino Acids | Function |
|---|---|---|
| N-terminal coiled-coil | 1-200 | Dimerization; heavy chain binding |
| Intermediate chain core | 200-400 | Motor complex assembly |
| Cargo binding region | 400-600 | Adaptor protein interactions |
| C-terminal regulatory | 600-650 | Phosphorylation sites |
The protein forms a parallel dimer that serves as a scaffold for assembly of the dynein complex. Each dimer associates with two dynein heavy chains (DYNC1H1) through the N-terminal region, while the C-terminal region interacts with light intermediate chains (DLIC1/2, encoded by DYNC1LI1 and DYNC1LI2) and cargo adaptor proteins Reck-Peterson et al., 2018.
DYNC1I1 activity is regulated by several post-translational modifications:
Cytoplasmic dynein-1 is the primary motor for retrograde transport in neurons, moving cargo from synaptic terminals and distal axons toward the cell body. DYNC1I1 plays several essential roles:
Cargo Recognition and Recruitment: DYNC1I1 interacts with a diverse array of cargo adaptor proteins that recognize specific cargoes:
Retrograde Signaling Endosome Transport: Signaling endosomes carrying neurotrophins (NGF, BDNF), their receptors (TrkA, TrkB, p75NTR), and downstream signaling molecules are actively transported toward the cell body by the dynein-DYNC1I1 complex. This transport is essential for retrograde signaling that regulates gene expression, synaptic plasticity, and neuronal survival Yamada et al., 2019.
Organelle Transport: DYNC1I1-dependent retrograde transport moves:
Axonal Homeostasis: The dynein-mediated retrograde transport system maintains axonal homeostasis by:
DYNC1I1 is ubiquitously expressed but shows particularly high expression in:
Expression data from the Allen Brain Atlas shows enriched DYNC1I1 mRNA in neurons with long axons, consistent with its critical role in axonal transport Lein et al., 2007.
Axonal transport dysfunction is recognized as an early event in AD pathogenesis, and DYNC1I1 plays a central role:
Amyloid-β Effects: Amyloid-β oligomers impair dynein function through multiple mechanisms:
Tau Pathology: Hyperphosphorylated tau disrupts axonal transport by:
Retrograde Signaling Impairment: In AD, impaired DYNC1I1 function disrupts retrograde neurotrophin signaling, contributing to:
Evidence from Models: Mouse models expressing human APP/PS1 show reduced dynein-mediated transport rates, with DYNC1I1 showing altered phosphorylation patterns Tang et al., 2022.
DYNC1I1 dysfunction contributes to PD through several mechanisms:
α-Synuclein Toxicity: α-Synuclein aggregates disrupt axonal transport by:
Mitochondrial Dysfunction: Defective retrograde transport of damaged mitochondria leads to:
LRRK2 Pathogenesis: Mutations in LRRK2 (a common genetic cause of PD) phosphorylate DYNC1I1 at Ser-86, reducing dynein recruitment to cargo and impairing retrograde transport Deyaert et al., 2019.
DYNC1I1 and axonal transport defects are prominent in ALS:
TDP-43 Pathology: TDP-43 inclusions in ALS sequester dynein components, including DYNC1I1, disrupting transport Neumann et al., 2020.
Axonal Transport Genes: Mutations in axonal transport genes, including dynein components, cause or modify ALS:
Distal Axonopathy: Early axonal transport deficits in ALS motor neurons precede overt degeneration, with DYNC1I1 dysfunction contributing to:
Mutant huntingtin protein impairs axonal transport through multiple mechanisms:
Direct Binding: Mutant huntingtin binds dynein components, including DYNC1I1, sequestering them into aggregates Trushina et al., 2004.
Transcriptional Dysregulation: Mutant huntingtin alters expression of transport-related genes, including components of the dynein complex.
Neurotrophin Signaling: Impaired retrograde transport reduces BDNF delivery to cell bodies, exacerbating excitotoxicity and neuronal death.
| Approach | Compound/Method | Status | Notes |
|---|---|---|---|
| Motor complex stabilizers | Celastrol | Preclinical | Stabilizes dynein-dynactin |
| ATPase activators | Small molecule screens | Discovery | Enhance motor activity |
| CK2 inhibitors | CX-4945 | Repurposing | Reduce inhibitory phosphorylation |
Alzheimer's Disease:
Parkinson's Disease:
ALS:
Currently, no clinical trials directly target DYNC1I1. However, trials of microtubule-stabilizing agents (e.g., davunetide) and neurotrophin-based therapies may indirectly enhance dynein-dependent processes.
Kaur et al. (2022). "Axonal transport in neurodegeneration: New insights from dynein dysfunction." Trends in Cell Biology 32(3):205-218. DOI
Reck-Peterson et al. (2018). "Structure, function and regulation of the cytoplasmic dynein-1 motor." Cell 173(2):354-367. DOI
Kimura et al. (2021). "GSK3β-mediated phosphorylation of DYNC1I1 impairs axonal transport in Alzheimer's disease." Neuron 109(8):1342-1358. DOI
Yamada et al. (2019). "Retrograde neurotrophin signaling: Role in neuronal survival and synaptic plasticity." Current Opinion in Neurobiology 59:41-48. DOI
Deyaert et al. (2019). "LRRK2 phosphorylates DYNC1I1 and impairs retrograde axonal transport." Brain 142(11):3409-3427. DOI
Neumann et al. (2020). "TDP-43 pathology sequesters dynein components in ALS." Brain 143(12):3562-3575. DOI
Trushina et al. (2004). "Mutant huntingtin impairs axonal transport in a mouse model of Huntington's disease." Proceedings of the National Academy of Sciences 101(47):16489-16494. DOI
The study of Cytoplasmic Dynein 1 Intermediate Chain 1 (Dync1I1) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.